Ismail Baris Turkbey, M.D.
Dr. Turkbey’s main research interests focus on prostate cancer imaging (multiparametric MRI, PET CT), prostate biopsy techniques, focal therapy for prostate cancer and image processing (segmentation, decision support systems). Dr. Turkbey directs the Artificial Intelligence Resource (AIR), which makes AI tools available to CCR investigators with the goal of developing better screening and detection methods or predictive markers for patients.
1) imaging, 2) prostate cancer, 3) lymphatic imaging, 4) experimental MRI
- CA Cancer J Clin. 28: Epub ahead of print, 2015. [ Journal Article ]
- AJR Am J Roentgenol. 38: 64-9, 2015. [ Journal Article ]
Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.Radiology. 741-50, 2015. [ Journal Article ]
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.JAMA. 313(4): 390-7, 2014. [ Journal Article ]
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.Radiology. 255(1): 89-99, 2010. [ Journal Article ]
Dr. Turkbey obtained his medical degree from Hacettepe University in Ankara, Turkey in 2003. He completed his residency in Diagnostic and Interventional Radiology at Hacettepe University. He joined Molecular Imaging Program, National Cancer Institute, NIH in 2007. His main research areas are imaging of prostate cancer (multiparametric MRI, PET CT), prostate biopsy techniques, focal therapy for prostate cancer and image processing (segmentation, decision support systems).
|Stephanie Harmon||Scientist I (Leidos)|
|Deepak Kesani M.D.||Special Volunteer|
|Sherif Mehralivand Ph.D.||Postdoctoral Fellow (Visiting)|
|Jonathan Sackett||MRSP Fellow|
|Thomas Sanford M.D.||Clinical Fellow|